Candicidin: Difference between revisions
m Protected "Candicidin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name | | Verifiedfields = changed | ||
| image | | Watchedfields = changed | ||
| verifiedrevid = 460122980 | |||
| | | IUPAC_name = 33-[(3-Amino-3,6-dideoxy-<small>D</small>-mannopyranosyl)oxy]-17-[6-(4-aminophenyl)-4-hydroxy-1,3-dimethyl-6-oxohexyl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid | ||
| image = Candicidin.png | |||
<!--Clinical data--> | |||
| tradename = | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | |||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | |||
| pregnancy_AU | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_US | | legal_status = | ||
| pregnancy_category= | | routes_of_administration = | ||
| legal_AU | |||
| legal_CA | <!--Pharmacokinetic data--> | ||
| legal_UK | | bioavailability = | ||
| legal_US | | protein_bound = | ||
| legal_status | | metabolism = | ||
| routes_of_administration = | | elimination_half-life = | ||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 1403-17-4 | |||
| ATC_prefix = G01 | |||
| ATC_suffix = AA04 | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C59H84N2O18/c1-35-18-15-13-11-9-7-5-6-8-10-12-14-16-21-46(77-58-55(72)53(61)54(71)38(4)76-58)31-50-52(57(73)74)49(69)34-59(75,79-50)33-45(66)29-44(65)28-43(64)27-41(62)19-17-20-42(63)30-51(70)78-56(35)37(3)26-36(2)47(67)32-48(68)39-22-24-40(60)25-23-39/h5-16,18,21-25,35-38,43-47,49-50,52-56,58,64-67,69,71-72,75H,17,19-20,26-34,60-61H2,1-4H3,(H,73,74)/b6-5-,9-7-,10-8-,13-11-,14-12-,18-15-,21-16-/t35?,36?,37?,38-,43?,44?,45?,46?,47?,49?,50?,52?,53+,54-,55+,56?,58?,59?/m1/s1 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = YKSVGLFNJPQDJE-WDANKXQLSA-N | |||
| PubChem = 441142 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB01152 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 10128184 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 48N2IYJ202 | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 1200647 | |||
<!--Chemical data--> | |||
| C=59 | H=84 | N=2 | O=18 | |||
| molecular_weight = 1109,32 g/mol | |||
| smiles = Nc1ccc(cc1)C(=O)CC(O)C(C)CC(C)C3OC(=O)CC(=O)CCCC(=O)CC(O)CC(O)CC(O)CC4(O)CC(O)C(C(=O)O)C(CC(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C=CC=CC=CC=CC=CC=CC=CC3C)O4 | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{ | {{CMG}} | ||
==Overview== | |||
'''Candicidin''' is an [[Antifungal medication|antifungal]] compound obtained from ''[[Streptomyces]] griseus''. It is active against some fungi including ''[[Candida albicans]]''. Candicidin is administered intravaginally in the treatment of vulvovaginal [[candidiasis]].<ref>{{ cite web | title = Product information Candicidin | url = http://www.toku-e.com/Upload/Products/PDS/20120604006556.pdf | format = pdf | publisher = Toku-E | date = 2012-01-11 | accessdate = 2012-06-11 }}</ref> | |||
'''Candicidin'' | This [[Bioactive compounds|bioactive compound]] was named candicidin, because of its high activity on '' Candida albicans''.<ref>Selman A. Waksman, Hubert A. Lechevalier & Carl P. Schaffner: ''Candicidin and other Polyenic Antifungal Antibiotics'', 1965, 33, 219-226</ref> | ||
== References == | |||
{{reflist|2}} | |||
{{Gynecological anti-infectives and antiseptics}} | {{Gynecological anti-infectives and antiseptics}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Antifungals]] | |||
Latest revision as of 13:39, 10 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C59H84N2O18 |
Molar mass | 1109,32 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Candicidin |
Articles |
---|
Most recent articles on Candicidin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Candicidin at Clinical Trials.gov Clinical Trials on Candicidin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Candicidin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Candicidin Discussion groups on Candicidin Patient Handouts on Candicidin Directions to Hospitals Treating Candicidin Risk calculators and risk factors for Candicidin
|
Healthcare Provider Resources |
Causes & Risk Factors for Candicidin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Candicidin is an antifungal compound obtained from Streptomyces griseus. It is active against some fungi including Candida albicans. Candicidin is administered intravaginally in the treatment of vulvovaginal candidiasis.[1]
This bioactive compound was named candicidin, because of its high activity on Candida albicans.[2]
References
- ↑ "Product information Candicidin" (pdf). Toku-E. 2012-01-11. Retrieved 2012-06-11.
- ↑ Selman A. Waksman, Hubert A. Lechevalier & Carl P. Schaffner: Candicidin and other Polyenic Antifungal Antibiotics, 1965, 33, 219-226